In March 2024, Catherine, the Princess of Wales, announced her cancer diagnosis. The 42-year-old did not reveal the type of cancer she was facing but shared that she had undergone major abdominal ...

Cryotherapy is emerging as a promising, low-risk approach to combat chemotherapy-induced peripheral neuropathy, a common and potentially devastating toxicity of chemotherapy. A growing body of ...

Chemotherapy is a mainstay in the treatment of cancer and may be used alone or in combination with other treatment approaches, such as radiation and surgery, to combat the disease. However, while ...

Milan, Italy: Patients with triple-negative breast cancer do not benefit from the addition of atezolizumab to their post-surgery chemotherapy treatment, according to the results of a large phase 3 ...

Ian Olver receives funding from the Australian Research Council. Catherine, Princess of Wales, is undergoing treatment for cancer. In a video thanking followers for their messages of support after her ...

If you missed NewsNation’s “Killing Cancer: The Power Within” special report, you can see an encore presentation on Thursday at 9p/8C. Click here to find NewsNation in your lineup. (NewsNation) — ...

The use of olaparib as a monotherapy or in combination with cediranib did not provide a statistically significance overall survival (OS) benefit compared with standard of care platinum-based ...

Patritumab deruxtecan showed no overall survival benefit over chemotherapy in EGFR mutation-positive NSCLC patients. The drug demonstrated a slight progression-free survival advantage and higher ...

Chemotherapy is an emotional and physical challenge that affects many aspects of your life, including your appearance. One of the most visible changes during chemotherapy is hair loss. Though this ...